Introduction
============

Chromosome 15q24 microdeletion syndrome is a rare disease that was first analyzed by [@ref-19], characterizing the phenotype and genotype of four patients with this syndrome ([@ref-19]). Since this publication, further papers have contributed new cases, providing descriptive comparisons of the phenotype and genotype between the new case and those already described ([@ref-8]; [@ref-11]; [@ref-1]; [@ref-4]; [@ref-13]; [@ref-20]; [@ref-5]; [@ref-14]; [@ref-9]; [@ref-2]; [@ref-15]; [@ref-16]; [@ref-18]). Five breakpoints (Low-Copy Repeat \[LCR\] clusters) have been identified where the majority of the microdeletions have occurred: LCR15q24A, LCR15q24B, LCR15q24C, LCR15q24D, and LCR15q24E ([@ref-10]).

As a result of these reports, in January 2012 [@ref-10] conducted a comprehensive review of the cases reported up to that time ([@ref-10]). In this review they descriptively analyzed the phenotypes of the patients with the syndrome, both in detail and in large groups. However, as this work did not include inferential statistics calculating the proportion of children with the different phenotypes with their Confidence Intervals (CI), we conducted a study to update the literature search and to determine the corresponding ranges for each phenotype using bootstrap methodology. The results provide a better understanding of this rare condition.

Materials and Methods
=====================

Study population
----------------

The population included all individuals with chromosome 15q24 microdeletion syndrome.

Study design and participants
-----------------------------

This pooled analysis study examined *MEDLINE* and *Google Scholar* databases for reported cases of patients with the syndrome, using the keywords *15q24, deletion* and *microdeletion*. The references in all the cases obtained were reviewed to detect possible studies not found in the databases analyzed, in order to collect all the papers that had been used as references to cases of the syndrome. This search was updated on September 29, 2015.

Starting with the second published case report, the authors compared the characteristics of their patients with the published cases ([@ref-8]; [@ref-11]; [@ref-1]; [@ref-4]; [@ref-13]; [@ref-20]; [@ref-5]; [@ref-14]; [@ref-9]; [@ref-2]; [@ref-15]; [@ref-16]; [@ref-18]). We analyzed all the references in these case reports in order to obtain the maximum sample size.

Variables and measurements
--------------------------

First, we determined which children had each of these phenotypes: male gender, developmental delay, low birth weight/intrauterine growth restriction, short stature, obesity, microcephaly, feeding difficulties, long face, facial asymmetry, high anterior hairline, epicanthal folds, hypertelorism, downslanting palpebral fissures, sparse and broad medial eyebrows, strabismus, nystagmus, broad nasal base, depressed nasal bridge, high nasal bridge, ear abnormalities, palate abnormalities, long smooth philtrum, full lower lip, small mouth, hypospadias, microphallus, cryptorchidism, thumb abnormalities, brachydactyly/short digits, clynodactyly, toe abnormalities, joint laxity, scoliosis/kyphosis, hypotonia, behavior problems, Magnetic Resonance Imaging (MRI) abnormalities, recurrent infections, hernias, congenital heart disease, hearing loss, diaphragmatic hernia, intestinal atresia, imperforate anus, coloboma, dental problems and myelomeningocele. The phenotypes used followed the previous review ([@ref-5]). The deleted megabase (Mb) pairs in each patient were determined to calculate the size of the interstitial deletion of chromosome 15q24 (in Mb). Finally, we also analyzed the five breakpoints ([@ref-10]).

The source of information was the selected papers, i.e., those containing complete information on phenotype and genotype (Mb).

Sample size
-----------

The sample size was 40 patients, 4 of whom were excluded due to lack of the information required for this study (Mb and phenotype). The final sample consisted of 36 patients.

Statistical methods
-------------------

The phenotype was described using absolute frequencies. One thousand bootstrap samples were obtained to determine the relative distribution frequency for the phenotypes and the mean loss size of the interstitial deletion of chromosome 15q24 (in Mb). Using these samples, we calculated a point estimate (median) and a CI (percentiles method) for these parameters (proportions and means). Thus we obtained a measurement of the uncertainty for the relative frequencies and for the mean, since with a small sample size we could not perform an asymptotic approximation of the normal distribution (n = 36). This bootstrap methodology was based on taking 1,000 simple random samples with replacement of the original sample. For each sample we calculated the statistic of interest (in our case proportions/means). At the end of the process we obtained 1,000 values for the statistic. In other words, we had a distribution of the statistic from which we could then calculate its estimation (median) with its CI (P2.5--P97.5). This method is very useful for obtaining the CI for statistics which are difficult to calculate (no closed form or with hypotheses which are not present). The computational cost is the only aspect of this method that is inadequate, but as our sample was small, this was not a problem. This methodology has already been applied with other rare diseases ([@ref-3]). All analyses were performed with a significance level of 5%. The statistical software used was IBM SPSS Statistics 19.

Results
=======

[Table 1](#table-1){ref-type="table"} shows the descriptive and analytical features of all the patients found in the literature search. We highlight the wide variability in the prevalence of the different phenotypes (3--100%). The phenotype with the lowest prevalence was myelomeningocele, which was only present in one case, whereas developmental delay was common in all cases (n = 36). The mean interstitial deletion loss was 2.72 Mb (95% CI \[2.35--3.10 Mb\]). Regarding the five breakpoints, we obtained the following results (patients who presented the deletion at the breakpoint): A) 19 (0.53, 95% CI \[0.36--0.69\]); B) 30 (0.83, 95% CI \[0.69--0.94\]); C) 25 (0.69, 95% CI \[0.56--0.86\]); D) 11 (0.31, 95% CI \[0.17--0.47\]); and E) 9 (0.25, 95% CI \[0.11--0.39\]).
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###### Descriptive and analytical features of the phenotypes of the patients with chromosome 15q24 microdeletion syndrome.
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  Phenotype                         Total n = 36   Proportion (95% CI)   Phenotype                                        Total n = 36   Proportion (95% CI)
  --------------------------------- -------------- --------------------- ------------------------------------------------ -------------- ---------------------
  Male gender                       27             0.75 (0.61--0.89)     Small mouth                                      9              0.25 (0.11--0.39)
  Developmental delay               36             1 (1--1)              Hypospadias                                      9              0.25 (0.11--0.39)
  Low birth weight/IUGR             14             0.39 (0.22--0.56)     Microphallus[^\*^](#table-1fn2){ref-type="fn"}   5              0.19 (0.04--0.36)
  Short stature                     11             0.31 (0.17--0.47)     Cryptorchidism                                   4              0.11 (0.03--0.22)
  Obesity                           8              0.22 (0.08--0.36)     Thumb abnormalities                              8              0.22 (0.11--0.36)
  Microcephaly                      8              0.22 (0.08--0.36)     Brachydactyly/short digits                       12             0.33 (0.19--0.50)
  Feeding difficulties              7              0.19 (0.08--0.33)     Clynodactyly                                     3              0.08 (0.00--0.19)
  Long face                         9              0.25 (0.11--0.42)     Toe abnormalities                                10             0.28 (0.14--0.44)
  Facial asymmetry                  5              0.14 (0.03--0.25)     Joint laxity                                     14             0.39 (0.22--0.56)
  High anterior hairline            11             0.31 (0.17--0.47)     Scoliosis/Kyphosis                               8              0.22 (0.08--0.36)
  Epicanthal folds                  17             0.47 (0.31--0.64)     Hypotonia                                        18             0.50 (0.33--0.64)
  Hypertelorism                     8              0.22 (0.08--0.36)     Behavior problems                                16             0.44 (0.28--0.58)
  Downslanting palpebral fissures   15             0.42 (0.25--0.58)     MRI abnormalities                                13             0.36 (0.19--0.53)
  Sparse broad medial eyebrows      15             0.42 (0.25--0.58)     Recurrent infections                             11             0.31 (0.17--0.44)
  Strabismus                        10             0.28 (0.14--0.44)     Hernias                                          5              0.14 (0.03--0.28)
  Nystagmus                         3              0.08 (0.00--0.19)     Congenital heart disease                         8              0.22 (0.11--0.36)
  Broad nasal base                  5              0.14 (0.03--0.25)     Hearing loss                                     10             0.28 (0.14--0.42)
  Depressed nasal bridge            6              0.17 (0.06--0.31)     Diaphragmatic hernia                             2              0.06 (0.00--0.14)
  High nasal bridge                 2              0.06 (0.00--0.14)     Intestinal atresia                               2              0.06 (0.00--0.14)
  Ear abnormalities                 21             0.58 (0.42--0.75)     Imperforate anus                                 2              0.06 (0.00--0.14)
  Palate abnormalities              8              0.22 (0.08--0.36)     Coloboma                                         2              0.06 (0.00--0.14)
  Long smooth philtrum              15             0.42 (0.25--0.58)     Dental problems                                  3              0.08 (0.00--0.19)
  Full lower lip                    9              0.25 (0.14--0.42)     Myelomeningocele                                 1              0.03 (0.00--0.08)

**Notes:**

CI, confidence interval; IUGR, intrauterine growth restriction; MRI, magnetic resonance imaging.

Only for male gender.

Discussion
==========

Summary
-------

This study updates the descriptive analysis of the different phenotypes conducted in 2012 ([@ref-10]), and provides inferential information on a range of values within which the true proportion of each phenotype in the study population can likely be found (95% CI).

Strengths and limitations of the study
--------------------------------------

The main strength of this study is that, for the first time, a measurement of the uncertainty of the proportion of each phenotype in the population has been obtained using inferential statistics (bootstrap samples). In addition, the descriptive data provided by [@ref-10] have also been updated.

Concerning the limitations of this study, we have to assume a possible selection bias, since it is possible that not all incident cases of this syndrome have been published or that in our search strategy we may not have found all recently published cases, as we did not include the DECIPHER and ECARUCA databases. To minimize this bias as much as possible, we rigorously reviewed all the references for each of the articles. In terms of reporting bias, it is possible that not all the features have been specified in each of the cases. For example, MRI abnormalities: not all reported patients would have had an MRI scan done. In those cases the statistics for MRI abnormalities would be difficult to derive. Regarding obesity, the other authors used the Z-score for its assessment. In other words, the researchers took into account the age and gender of the patients. Other features are largely descriptive (thumb abnormalities, hypertelorism and brachydatyly) and thus subject to single clinical observer bias. Finally, the information was obtained through the publications instead of by contacting the authors. For obvious reasons, this information bias cannot be minimized. If we were analyzing associations between phenotypes and genotypes, this bias could give us incorrect information about the associations. However, we only obtained descriptive statistics with their confidence interval using the original sample through bootstrap methodology.

Comparison with the existing literature
---------------------------------------

To compare our results with those found by the 2012 study ([@ref-10]), we determined whether the point estimate given by the previous study was within the CI we constructed for each phenotype. Such that if the estimate of the other study fell within that range, we had no evidence indicating that the proportion was different from that of our study ([@ref-10]). However, if this estimate fell outside our CI, there was a difference compared with our study.

Overall we found agreement between both studies, as the previous estimate in nearly 83% of the phenotypes (38/46) was within our CI. The eight phenotypes that showed discrepancies with the previous study ([@ref-10]) were facial asymmetry, high anterior hairline, hypertelorism, broad nasal base, hypospadias, microphallus, thumb abnormalities, and clynodactyly, all of which were approximately twice as prevalent in the earlier study ([@ref-10]) than in our study. To assess the reasons for these discrepancies we need further studies on this syndrome, because they cannot be determined using our study design.

Implications for research and/or practice
-----------------------------------------

The comparative analysis between our results and those of the review published in 2012 ([@ref-10]) revealed differences in 17% of the phenotypes. Given that the previous article was accepted for publication in January 2012 ([@ref-10]), and that our work expanded the literature analysis by approximately 45 months, it appears that the prevalence of the phenotypes in these patients is not fully known, which suggests the need for future studies in this rare syndrome. When there are more published cases of this rare syndrome, it would be very interesting to determine associations between the phenotypes and the size of the deletion. These associations were not studied in our paper because with 36 patients we would not have been able to obtain valid conclusions. Finally, it would be interesting to measure some phenotypes with facial recognition software (facial asymmetry, high anterior hairline, hypertelorism and broad nasal base).

Once we have this new knowledge, we can devise strategies to improve our decisions regarding these patients. For instance, we could attempt to determine where the breakpoint is using only the information about the phenotype.

Conclusions
===========

The prevalence of the different phenotypes in patients with chromosome 15q24 microdeletion syndrome, published in early 2012 ([@ref-10]), has been updated. The CI were calculated based on bootstrap samples for these proportions, providing a measurement of the uncertainty in the study population. Furthermore, differences between our study and the 2012 study were found in approximately one in six phenotypes, which suggests more studies are needed to analyze the characteristics of this rare syndrome.
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